MedPath

A Study to Evaluate the Efficacy of Abheerumuladi Ghrita in Children with Attention Deficit Hyperactivity Disorder

Phase 2
Conditions
Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type
Registration Number
CTRI/2023/07/054857
Lead Sponsor
Dr BALASREE R JEEVA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Children in the age group of 7-12 years, irrespective of their gender, religion and socio- economic status.

2.Children fulfilling the diagnostic criteria of ADHD as per DSM 5.

3.Children whose parents are willing to sign the written consent form and follow the treatment protocol will be included.

Exclusion Criteria

1.Children below 7 years and above 12 years of age will be excluded.

2.Children with other neurodevelopmental disorders and psychotic disorders like childhood Epilepsy, Mental Retardation, Pervasive Developmental Disorder not other-wise specified, Depression and Anxiety disorders, Rettâ??s syndrome, Conduct Disorder, Schizophrenia etc will be excluded.

3.Children with other systemic diseases will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of Attention Deficit Hyperactivity Disorder based on 33 items in ADHD T2 scale. Namely two sub scales - <br/ ><br>1. Inattention <br/ ><br>2. Hyperactivity/ ImpulsivityTimepoint: Before intervention - 0th day <br/ ><br>After intervention - 60th day, 90th day
Secondary Outcome Measures
NameTimeMethod
Assessment of Attention Deficit Hyperactivity Disorder by assessing Lakshanas of vibhramas mentioned in unmada like <br/ ><br>1. chesta vibhrama <br/ ><br>2. Achara vibhrama <br/ ><br>3. Bhakti vibhrama <br/ ><br>4. Smriti vibhramaTimepoint: Before intervention - 0th day <br/ ><br>After intervention - 60th day, 90th day
© Copyright 2025. All Rights Reserved by MedPath